Literature DB >> 19524642

HAX-1: a multifunctional protein with emerging roles in human disease.

Bengt Fadeel1, Ewa Grzybowska.   

Abstract

HS-1-associated protein X-1 (HAX-1) was identified more than 10 years ago as a novel protein with ubiquitous tissue expression and a predominantly mitochondrial localization at the subcellular level. Recent studies have shown that homozygous mutations in the HAX1 gene are associated with autosomal recessive forms of severe congenital neutropenia (also known as Kostmann disease), and results from studies in mice and men are beginning to unravel a prominent role for HAX-1 in apoptosis signaling not only in the hematopoietic compartment, but also in the central nervous system. Moreover, several different cellular and viral binding partners of HAX-1 have been identified thus pointing toward a complex and multifunctional role of this protein. HAX-1 has also been shown to bind to the 3' untranslated regions of certain mRNAs and could therefore contribute to the regulation of transport and/or stability of such transcripts. The present review discusses the emerging and divergent roles of HAX-1, including its involvement in cell migration, apoptosis signaling, and mRNA surveillance. The importance of HAX-1 in human disease is also highlighted and outstanding questions that remain to be addressed are identified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524642     DOI: 10.1016/j.bbagen.2009.06.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  51 in total

1.  Specific alterations of the HtrA2/HAX-1 ratio in the penumbra upon focal cerebral ischemia in mice.

Authors:  A Rami; A Langhagen
Journal:  Neurochem Res       Date:  2011-11-06       Impact factor: 3.996

2.  Molecular basis of congenital neutropenia.

Authors:  Christoph Klein
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 3.  HTRA proteases: regulated proteolysis in protein quality control.

Authors:  Tim Clausen; Markus Kaiser; Robert Huber; Michael Ehrmann
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02-16       Impact factor: 94.444

4.  Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export.

Authors:  Fawzi Alogaili; Sivaprakasam Chinnarasu; Anja Jaeschke; Evangelia G Kranias; David Y Hui
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

5.  Intrinsically disordered HAX-1 regulates Ca2+ cycling by interacting with lipid membranes and the phospholamban cytoplasmic region.

Authors:  Erik K Larsen; Daniel K Weber; Songlin Wang; Tata Gopinath; Daniel J Blackwell; Michael P Dalton; Seth L Robia; Jiali Gao; Gianluigi Veglia
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-08-07       Impact factor: 3.747

6.  Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.

Authors:  Nicole A Perry; Marey Shriver; Marie G Mameza; Bryan Grabias; Eric Balzer; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

7.  Expression of HAX-1 in human colorectal cancer and its clinical significance.

Authors:  Xiao-Jun Wei; Shi-Yong Li; Bo Yu; Guang Chen; Jun-Feng Du; Hui-Yun Cai
Journal:  Tumour Biol       Date:  2013-09-22

8.  Distant homologs of anti-apoptotic factor HAX1 encode parvalbumin-like calcium binding proteins.

Authors:  Katarzyna Kokoszyńska; Leszek Rychlewski; Lucjan S Wyrwicz
Journal:  BMC Res Notes       Date:  2010-07-15

9.  The anti-apoptotic protein HAX-1 is a regulator of cardiac function.

Authors:  Wen Zhao; Jason R Waggoner; Zhi-Guo Zhang; Chi Keung Lam; Peidong Han; Jiang Qian; Paul M Schroder; Bryan Mitton; Aikaterini Kontrogianni-Konstantopoulos; Seth L Robia; Evangelia G Kranias
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

10.  HAX-1 regulates SERCA2a oxidation and degradation.

Authors:  Philip A Bidwell; Guan-Sheng Liu; Narayani Nagarajan; Chi Keung Lam; Kobra Haghighi; George Gardner; Wen-Feng Cai; Wen Zhao; Luke Mugge; Elizabeth Vafiadaki; Despina Sanoudou; Jack Rubinstein; Djamel Lebeche; Roger Hajjar; Junichi Sadoshima; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2017-11-21       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.